Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
NCT07130929

Functional Electrical Stimulation to Treat Critical Neuromyopathy After Severe Stroke: a Pilot Study.

Led by Fondazione Don Carlo Gnocchi Onlus · Updated on 2025-12-11

24

Participants Needed

1

Research Sites

78 weeks

Total Duration

On this page

Sponsors

F

Fondazione Don Carlo Gnocchi Onlus

Lead Sponsor

U

University of Florence

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study aims to evaluate the effectiveness of physiotherapy treatment combined with functional electrical stimulation (FES) in a small group of patients with severe acquired brain injury (SABI) of vascular origin and with a clinical and instrumental diagnosis of "Intensive Care Unit-Acquired Weakness" (ICU-AW). Functional electrical stimulation is a technology that uses electrical impulses, generated by an external device, to reactivate the neuromuscular system through electrodes applied to the skin. In functional electrical stimulation, this process is integrated into physiotherapy sessions, with the active involvement of the patient, through the performance of exercises with the assistance and supervision of the physiotherapist. The rationale behind this is to stimulate neuroplasticity processes by facilitating movement through the application of electrical stimuli and the active participation of the patient in performing a motor task, in an attempt to promote improvement in an impaired function. In particular, the objectives that will be pursued are: improvement of lower limb neuromyopathy assessed clinically using the Medical Research Council (MRC) scale, the Fugl-Meyer scale for lower limbs, the Short Physical Performance Battery (SPPB) scale, the assessment of active and passive Range Of Motion (ROM) of the main joints of the lower limb (hip, knee, ankle) and measured instrumentally by neurophysiological examination and ultrasound examination. After randomization, patients in the control arm will be treated with physiotherapy and speech therapy sessions as per the conventional protocol, and an additional 15 physiotherapy sessions lasting 60 minutes over a period of 5 weeks. Alternatively, patients in the experimental group will receive, in addition to conventional rehabilitation treatment, a treatment consisting of 15 physiotherapy sessions combined with FES lasting 60 minutes over a period of 5 weeks. At the end of the treatment period, baseline characteristics and clinical and instrumental outcome variables will be compared between the two groups using the chi-square test for dichotomous and categorical variables and the t-test for independent samples or the Mann-Whitney U test for continuous variables, depending on whether or not they are normally distributed. In all analyses, a p-value \<0.05 will be considered significant.

CONDITIONS

Official Title

Functional Electrical Stimulation to Treat Critical Neuromyopathy After Severe Stroke: a Pilot Study.

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of ischemic or hemorrhagic vascular brain injury causing unilateral motor deficit less than 3 months ago
  • Premorbid Modified Rankin Scale less than 2
  • Age between 18 and 80 years
  • Level of Cognitive Functioning greater than 4 for active participation in treatment
  • Medical Research Council total sum score 48 or less indicating clinical suspicion of ICU-Acquired Weakness
  • Clinical diagnosis of tetra/paraparesis of peripheral origin confirmed by neurophysiological tests
  • Signed informed consent by the patient or legal representative
Not Eligible

You will not qualify if you...

  • Clinical cardio-respiratory or internal instability preventing treatment
  • History of previous comorbidity for ICU-Acquired Weakness
  • Known chronic neuropathy
  • Severe coagulopathy
  • Skin problems at sites where the electrostimulator would be applied
  • Epilepsy not controlled by medication
  • Presence of implanted electronic devices
  • Pregnancy or breastfeeding
  • Severe spasticity with a score greater than 3 on the modified Ashworth scale
  • Treatment with botulinum toxin
  • Recent malignant neoplasm
  • Conditions increasing risk for neuropathies such as diabetes, renal or hepatic failure, vitamin deficiencies, chronic alcoholism, vasculitis, or previous use of neurotoxic drugs

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

IRCCS-Fondazione Don Gnocchi

Florence, FI, Italy, 50143

Actively Recruiting

Loading map...

Research Team

B

Bahia Hakiki

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here